Ki Moo Lim

Prof. Ki Moo Lim


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DJDa Un Jeong
Da Un Jeong
KLKi Moo Lim
Ki Moo Lim
The pulse arrival time (PAT), the difference between the R-peak time of electrocardiogram (ECG) signal and the systolic peak of photoplethysmography (PPG) signal, is an indicator that enables noninvasive and continuous blood pressure estimation. However, it is difficult to accurately measure PAT from ECG and PPG signals because they have inconsistent shapes owing to patient-specific physical characteristics, pathological conditions, and movements. Accordingly, complex preprocessing is required to estimate blood pressure based on PAT. In this paper, as an alternative solution, we propose a noninvasive continuous algorithm using the difference between ECG and PPG as a new feature that can include PAT information. The proposed algorithm is a deep CNN–LSTM-based multitasking machine learning model that outputs simultaneous prediction results of systolic (SBP) and diastolic blood pressures (DBP). We used a total of 48 patients on the PhysioNet website by splitting them into 38 patients for training and 10 patients for testing. The prediction accuracies of SBP and DBP were 0.0 ± 1.6 mmHg and 0.2 ± 1.3 mmHg, respectively. Even though the proposed model was assessed with only 10 patients, this result was satisfied with three guidelines, which are the BHS, AAMI, and IEEE standards for blood pressure measurement devices.

29 December 2022 in Bioengineering
Verified
Journal Article
Open access
PDF file
YFYunendah Nur Fuadah
Yunendah Nur Fuadah
MPMuhammad Adnan Pramudito
Muhammad Adnan Pramudito
KLKi Moo Lim
Ki Moo Lim
Heart-sound auscultation is one of the most widely used approaches for detecting cardiovascular disorders. Diagnosing abnormalities of heart sound using a stethoscope depends on the physician’s skill and judgment. Several studies have shown promising results in automatically detecting cardiovascular disorders based on heart-sound signals. However, the accuracy performance needs to be enhanced as automated heart-sound classification aids in the early detection and prevention of the dangerous effects of cardiovascular problems. In this study, an optimal heart-sound classification method based on machine learning technologies for cardiovascular disease prediction is performed. It consists of three steps: pre-processing that sets the 5 s duration of the PhysioNet Challenge 2016 and 2022 datasets, feature extraction using Mel frequency cepstrum coefficients (MFCC), and classification using grid search for hyperparameter tuning of several classifier algorithms including k-nearest neighbor (K-NN), random forest (RF), artificial neural network (ANN), and support vector machine (SVM). The five-fold cross-validation was used to evaluate the performance of the proposed method. The best model obtained classification accuracy of 95.78% and 76.31%, which was assessed using PhysioNet Challenge 2016 and 2022, respectively. The findings demonstrate that the suggested approach obtained excellent classification results using PhysioNet Challenge 2016 and showed promising results using PhysioNet Challenge 2022. Therefore, the proposed method has been potentially developed as an additional tool to facilitate the medical practitioner in diagnosing the abnormality of the heart sound.

1 August 2023 in Diagnostics
Verified
Journal Article
Open access
PDF file
NMNurul Qashri Mahardika
Nurul Qashri Mahardika
YFYunendah Nur Fuadah
Yunendah Nur Fuadah
DJDa Un Jeong
Da Un Jeong
KLKi Moo Lim
Ki Moo Lim
Researchers commonly use continuous noninvasive blood-pressure measurement (cNIBP) based on photoplethysmography (PPG) signals to monitor blood pressure conveniently. However, the performance of the system still needs to be improved. Accuracy and precision in blood-pressure measurements are critical factors in diagnosing and managing patients’ health conditions. Therefore, we propose a convolutional long short-term memory neural network (CNN–LSTM) with grid search ability, which provides a robust blood-pressure estimation system by extracting meaningful information from PPG signals and reducing the complexity of hyperparameter optimization in the proposed model. The multiparameter intelligent monitoring for intensive care III (MIMIC III) dataset obtained PPG and arterial-blood-pressure (ABP) signals. We obtained 75,226 signal segments, with 60,180 signals allocated for training data, 12,030 signals allocated for the validation set, and 15,045 signals allocated for the test data. During training, we applied five-fold cross-validation with a grid-search method to select the best model and determine the optimal hyperparameter settings. The optimized configuration of the CNN–LSTM layers consisted of five convolutional layers, one long short-term memory (LSTM) layer, and two fully connected layers for blood-pressure estimation. This study successfully achieved good accuracy in assessing both systolic blood pressure (SBP) and diastolic blood pressure (DBP) by calculating the standard deviation (SD) and the mean absolute error (MAE), resulting in values of 7.89 ± 3.79 and 5.34 ± 2.89 mmHg, respectively. The optimal configuration of the CNN–LSTM provided satisfactory performance according to the standards set by the British Hypertension Society (BHS), the Association for the Advancement of Medical Instrumentation (AAMI), and the Institute of Electrical and Electronics Engineers (IEEE) for blood-pressure monitoring devices.

16 July 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BKBharindra Kamanditya
Bharindra Kamanditya
YFYunendah Nur Fuadah
Yunendah Nur Fuadah
NTNurul Qashri Mahardika T.
Nurul Qashri Mahardika T.
KLKi Moo Lim
Ki Moo Lim
Continuous blood pressure (BP) monitoring is essential for managing cardiovascular disease. However, existing devices often require expert handling, highlighting the need for alternative methods to simplify the process. Researchers have developed various methods using physiological signals to address this issue. Yet, many of these methods either fall short in accuracy according to the BHS, AAMI, and IEEE standards for BP measurement devices or suffer from low computational efficiency due to the complexity of their models. To solve this problem, we developed a BP prediction system that merges extracted features of PPG and ECG from two pulses of both signals using convolutional and LSTM layers, followed by incorporating the R-to-R interval durations as additional features for predicting systolic (SBP) and diastolic (DBP) blood pressure. Our findings indicate that the prediction accuracies for SBP and DBP were 5.306 ± 7.248 mmHg with a 0.877 correlation coefficient and 3.296 ± 4.764 mmHg with a 0.918 correlation coefficient, respectively. We found that our proposed model achieved a robust performance on the MIMIC III dataset with a minimum architectural design and high-level accuracy compared to existing methods. Thus, our method not only meets the passing category for BHS, AAMI, and IEEE guidelines but also stands out as the most rapidly accurate deep-learning-based BP measurement device currently available.

19 November 2018 in Sensors
Verified
Journal Article
Open access
PDF file
DKDae Hoon Kim
Dae Hoon Kim
HOHong Gi Oh
Hong Gi Oh
WPWoo Hwan Park
Woo Hwan Park
DJDong Cheol Jeon
Dong Cheol Jeon
KLKi Moo Lim
Ki Moo Lim
KSKwang Soup Song
Kwang Soup Song
The detection of alpha-fetoprotein (AFP) in plasma is important in the diagnosis of hepatocellular carcinoma (HCC) in humans. We developed a biosensor to detect AFP in HCC patient plasma and in a phosphate buffer saline (PBS) solution using a graphene field-effect transistor (G-FET). The G-FET was functionalized with 1-pyrenebutyric acid N-hydroxysuccinimide ester (PBASE) for immobilization of an anti-AFP antibody. AFP was detected by assessing the shift in the voltage of the Dirac point (ΔVDirac) after binding of AFP to the anti-AFP-immobilized G-FET channel surface. This anti-AFP-immobilized G-FET biosensor was able to detect AFP at a concentration of 0.1 ng mL−1 in PBS, and the detection sensitivity was 16.91 mV. In HCC patient plasma, the biosensor was able to detect AFP at a concentration of 12.9 ng mL−1, with a detection sensitivity of 5.68 mV. The sensitivity (ΔVDirac) depended on the concentration of AFP in either PBS or HCC patient plasma. These data suggest that G-FET biosensors could have practical applications in diagnostics.

20 September 2019 in Frontiers in Physiology
Verified
Journal Article
Open access
GTGetu Tadele Taye
Getu Tadele Taye
ESEun Bo Shim
Eun Bo Shim
Han-Jeong HwangHan-Jeong Hwang
Han-Jeong Hwang
KLKi Moo Lim
Ki Moo Lim
Early prediction of the occurrence of ventricular tachyarrhythmia (VTA) has a potential to save patients’ lives. VTA includes ventricular tachycardia (VT) and ventricular fibrillation (VF). Several studies have achieved promising performances in predicting VT and VF using traditional heart rate variability (HRV) features. However, as VTA is a life-threatening heart condition, its prediction performance requires further improvement. To improve the performance of predicting VF, we used the QRS complex shape features, and traditional HRV features were also used for comparison. We extracted features from 120-s-long HRV and electrocardiogram (ECG) signals (QRS complex signed area and R-peak amplitude) to predict the VF onset 30 s before its occurrence. Two artificial neural network (ANN) classifiers were trained and tested with two feature sets derived from HRV and the QRS complex shape based on a 10-fold cross-validation. The prediction accuracy estimated using 11 HRV features was 72%, while that estimated using four QRS complex shape features yielded a high prediction accuracy of 98.6%. The QRS complex shape could play a significant role in performance improvement of predicting the occurrence of VF. Thus, the results of our study can be considered by the researchers who are developing an application for an implantable cardiac defibrillator (ICD) when to begin ventricular defibrillation.